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A study was conducted to evaluate the molecular and cellular immunomodulatory 
effects of a Saccharomyces cerevisiae fermentation product (Original XPC, Diamond V) 
in broilers. Our lab has previously demonstrated that broilers fed XPC generate faster 
and stronger antigen-specific humoral immune responses to Newcastle disease virus 
(NDV) vaccination. This study aims at investigating the mechanism behind this increased 
immunocompetence. One-day-old broilers were randomly assigned to one of two treat-
ments: 1.25 kg/ton S. cerevisiae fermentation product (XPC treatment group) or control 
diet. Birds were vaccinated against NDV on day 1 (B1 strain) and day 21 (LaSota strain) 
post-hatch. Innate and adaptive immune-related gene expression profiles in central (thy-
mus and bursa of Fabricius) and peripheral (spleen) immune organs were investigated at 
14 and 28 days of age by qPCR array. Fold changes larger than 1.2 (P < 0.05) between 
treated and control were considered significant. Lymphocyte subpopulations in central 
and peripheral immune organs and blood leukocytes were analyzed by flow cytometry at 
14, 21, 28, and 42 days of age. In the spleen, Th1 immune responses and antiviral genes, 
such as IFN-γ, and its downstream genes signal transducer and activator of transcription 
(STAT4) and NFκB, were significantly upregulated in the treated group by 14 days of age. 
In the thymus, genes belonging to different functional groups were influenced at different 
time points. Cytokine genes associated with lymphocyte maturation, differentiation, and 
proliferation, such as IL-1R, IL-2, and IL-15 were significantly upregulated in the treated 
group by 28 days of age. Genes preferentially expressed in the medulla of the thymus and 
mature thymocytes, such as Myxovirus resistance gene 1, interferon regulatory factor-1, 
interferon regulatory factor-7, and STAT1, were upregulated in the birds supplemented 
with XPC. Birds supplemented with XPC had significantly higher percentages of CD3+, 
CD4+, and CD8+ T-cells in the thymus at day 28 of age, indicating production of more 
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inTrODUcTiOn
Over the past five decades, production efficiency including rapid 
growth, superior feed conversion, and high processing yield in 
the poultry industry have increased dramatically due to genetic 
selection (1, 2). Unfortunately, genetic selection for performance 
traits may result in negative impacts on immunity (1, 3). In the 
modern poultry industry, intensive production and confined 
housing conditions increase the risks of exposure to pathogens 
and stress factors (4). Therefore, several tools, including vaccina-
tion, biosecurity, antibiotic growth promoters, and nutritional 
immunomodulators, have been developed in order to maintain 
the balance between growth performance and the animal’s health 
and welfare. Recently, concerns over development of antimicro-
bial resistance from animals to humans led to changes in legisla-
tion regarding the use of antibiotics in poultry diets. Removal 
of antibiotic growth promoters has become desirable in light of 
evolving consumer demand. Thus, efforts have been focused on 
development of natural immunomodulators.
The characteristics of natural immunomodulators have been 
discussed in detail (4, 5). Recently, the immunological effects 
of Saccharomyces cerevisiae fermentation product (Original 
XPC™, Diamond V; referred as XPC in the following context) 
have been reported in several studies. Gao et al. (6) reported that 
supplementation with XPC not only resulted in better average 
daily weight gain and feed conversion rates through the improve-
ment of intestinal morphology but also stimulated both innate 
and humoral immunity. They demonstrated serum lysozyme 
and antigen-specific antibody titers significantly increased when 
broiler diets were supplemented with XPC. In the follow-up 
study, Gao et al. (7) further reported broilers whose diets were 
supplemented with XPC were able to recover body weight lost due 
to Eimeria tenella infection. XPC supplementation also increased 
T-cell repertoires in the spleen and peripheral blood, indicating 
an upregulation of cellular immunity in the XPC supplemented 
broilers. Similarly, Lensing et  al. (8) report supplementation 
with XPC decreased the severity of lesions after Eimeria maxima 
challenge. Despite the lack of evidence indicating a direct anti-
coccidian effect of dietary XPC, it has been suggested that XPC 
can help balance the immune system of broilers in an indirect 
manner. Supplementation with XPC also prevented absorption 
of aflatoxin in the intestinal tract of chickens (9). Taken together, 
these studies suggest that XPC supplementation is able to balance 
and modulate the immune system without compromising growth 
performance in broilers.
Our previous study also demonstrated that dietary supple-
mentation with XPC in broilers not only significantly improved 
feed conversion rate but also accelerated the establishment of 
a Newcastle disease virus (NDV)-specific humoral immune 
response when compared with non-supplemented broilers (10). 
While the beneficial effects of XPC supplementation on broiler 
immunity have been convincingly documented, the impact 
of supplementation on the immune cell repertoire and gene 
expression patterns in immune organs of broilers, especially after 
challenge, has yet to be addressed.
In the current manuscript, we further discuss the effect of 
dietary XPC on cell-mediated immunity (CMI) by measuring 
the lymphocyte repertoire in immune organs (bursa, thymus, and 
spleen) and peripheral blood on 14, 21, 28, and 42 days of age 
using four-color flow cytometry. Also, gene expression profiling 
in immune organs (bursa, thymus, and spleen) was performed 
at 14 and 28 days of age using the innate and adaptive immune 
response RT2 Profiler™ PCR array (SABiosciences, Frederick, 
MD, USA). This array profiles 84 immune-related genes function-
ally grouped into innate, adaptive, humoral immunity, inflamma-
tory response, and defense response against bacteria and viruses, 
which provides a comprehensive overview of the effects of XPC 
supplementation on an extensive array of the birds’ immune 
parameters upon challenge with a live-attenuated NDV vaccine.
MaTerials anD MeThODs
experimental Design
One hundred fifty broilers (Ross 708, Aviagen, Huntsville, AL, 
USA) were randomly assigned into control and treated groups at 
1 day of age. The dietary treatments consisted of 0 (Control) and 
1.25 kg/metric ton of S. cerevisiae fermentation product (XPC; 
Original XPC™, Diamond V, Cedar Rapids, IA, USA). Starter, 
grower, and finisher complete diets (Table 1) were manufactured 
at the Texas A&M University Poultry Research, Teaching and 
Extension Center. All the birds were vaccinated with 30 μL of 
live-attenuated NDV B1 strain vaccine (Merial, Duluth, GA, 
USA) on day 1 of age and boosted with live-attenuated NDV 
LaSota strain vaccine (Merial, Duluth, GA, USA) on 21 days of 
age via eye drop. In order to assess the effects of XPC on broiler 
CMI, immune organs and peripheral blood mononuclear cells 
(PBMC) were collected every 7 days (except for 35 days of age) 
from as early as 14 to 42 days of age (the end point of the experi-
ment). In addition, gene expression profiling of immune organs 
was performed at 14 and 28 days of age. All research on animals 
reported in this manuscript was approved by the Institutional 
Animal Care and Use Committee of Texas A&M University.
sample collection
In order to evaluate the effect of dietary XPC on the lymphocyte 
repertoire in broilers, five randomly selected chickens from each 
group were euthanized and immune organs (bursa, thymus, 
spleen, and blood) were harvested at 14, 21, 28, and 42 days of age. 
Half of each organ was processed for further lymphocyte isolation, 
mature T-cells, which was consistent with gene expression results. Results suggest 
that XPC supplementation primes broilers to become more immunocompetent, without 
compromising growth performance.
Keywords: Saccharomyces cerevisiae fermentation product, immunomodulation, qPcr, spleen, thymus
TaBle 1 | experimental diets and nutrient composition.
starter 
(0–14 days)
grower 
(15–28 days)
Finisher 
(29–42 days)
ingredients, %
Corn, yellow grain 58.46 64.73 68.53
Soybean meal, dehulled solvent 34.48 29.33 24.64
Bio Phos 16/21 P 1.56 1.59 1.29
Limestone 1.49 1.46 1.60
Salt, plain 0.51 0.49 0.46
Mineral mixa 0.05 0.05 0.05
dl-Methionine 0.28 0.08 0.16
Lysine 0.17 0.02 0.12
Vitamin premixb 0.25 0.25 0.25
Fat, A/V blend 2.75 2.00 2.90
Original XPCc 0.125 0.125 0.125
nutrient composition
Crude protein, % 22.02 19.80 17.99
ME, kcal/kg 3,048 3,055 3,151
Crude fat, % 5.30 4.74 5.73
Lysine, % 1.30 1.05 1.00
Methionine (M), % 0.61 0.39 0.44
M + Cysteine, % 0.97 0.72 0.75
Tryptophan, % 0.26 0.23 0.20
Threonine, % 0.82 0.74 0.67
Arginine, % 1.45 1.29 1.14
Valine, % 1.00 0.91 0.82
Calcium, % 0.92 0.90 0.89
Available phosphorus, % 0.45 0.45 0.38
Sodium, % 0.22 0.21 0.20
Chloride, % 0.39 0.34 0.35
aTrace mineral premix added at this rate yields 149.6 mg manganese, 55.0 mg zinc, 
26.4 mg iron, 4.4 mg copper, 1.05 mg iodine, 0.25 mg selenium, a minimum of 
6.27 mg calcium, and a maximum of 8.69 mg calcium per kilogram of diet. The carrier 
is calcium carbonate, and the premix contains less than 1% mineral oil.
bVitamin premix added at this rate yields 11,023 IU vitamin A, 3,858 IU vitamin D3, 
46 IU vitamin E, 0.0165 mg B12, 5.845 mg riboflavin, 45.93 mg niacin, 20.21 mg d-
pantothenic acid, 477.67 mg choline, 1.47 mg menadione, 1.75 mg folic acid, 7.17 mg 
pyroxidine, 2.94 mg thiamine, 0.55 mg biotin per kilogram diet. The carrier is ground 
rice hulls.
cDiamond V Original XPC, Cedar Rapids, IA, USA.
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while the other half was stored in RNAlater® (Life Technologies, 
Inc., Carlsbad, CA, USA) for gene expression profiling (1  mg 
tissue sample to 1  mL stabilization solution ratio). RNAlater® 
immersed samples were stored at −20°C until further analysis.
single cell suspension Preparation and 
lymphocyte isolation
Lymphocytes from spleen, bursa, and thymus were prepared 
according to previous published protocols with minor modifica-
tions (11). Briefly, freshly isolated immune organs were passed 
through 70 μM mesh cell strainers and lymphocytes, including 
mononuclear cells, were isolated by density gradient sedimenta-
tion using Ficoll-Hypaque (Histopaque-1077, Sigma-Aldrich, 
St. Louis, MO, USA). Isolated single cell suspensions were kept 
on ice until they were immunofluorescently stained for surface 
markers.
Similar procedures were applied to PBMC isolation (11). 
Briefly, 3 mL of peripheral blood was collected from the brachial 
vein in sodium citrate-containing tubes. PBMC were further 
isolated by density gradient sedimentation method as previously 
described. Isolated PBMC were kept on ice until immunofluores-
cent staining was performed.
lymphocyte subset analysis by Flow 
cytometry
All the primary monoclonal antibodies were purchased from 
Southern Biotech (Birmingham, AL, USA). Freshly prepared sin-
gle cell suspensions were treated with 25 mg/mL of mouse whole 
molecule IgG (Jackson Immunoresearch, West Grove, PA, USA) 
on ice for 30 min to avoid non-specific Fc receptor binding. Four-
color immunostaining with FITC-conjugated-anti-CD3 (0.5 mg/
mL), R-PE-conjugated anti-CD4 (0.1  mg/mL), Cy5-conjugated 
anti-CD8 (0.1 mg/mL), and biotinylated Bu-1 (0.5 mg/mL) were 
adapted for the current study. Single-color staining was used 
for compensation of overlapping spectra. After staining with 
dye-conjugated primary antibodies, all samples were centrifuged 
at 1,500 × g for 5 min at 4°C and washed three times with fluo-
rescence-activated cell sorting (FACS) buffer (10% FBS and 0.1% 
sodium azide in PBS, pH 7.4). After washing, 0.5 μg/mL of Pac-
Blue conjugated streptavidin (Jackson ImmunoResearch) was 
added and incubated in the dark for 15 min at 4°C, then washed 
2 times with FACS buffer. The stained samples were re-suspended 
with FACS buffer and fixed with 2% (w/v) phosphate-buffered 
paraformaldehyde. Data were acquired on a BD FACSAria II cell 
sorter system (BD Biosciences, San Jose, CA, USA) and analyzed 
with FlowJo version 8.8.4 software (Tree Star, Ashland, OR, USA). 
Results were analyzed by performing the Student’s t-test between 
control and XPC group using JMP software (SAS Institute, Cary, 
NC, USA). Statistical significance was determined at P < 0.05.
gene expression analysis by Quantitative 
Pcr array
Total RNA was extracted from bursa, thymus, and spleen using 
the Trizol® method according to manufacturer’s instructions. 
Total RNA samples were then converted into cDNA using the 
RT2 First Strand Kit (SABiosciences, Frederick, MD, USA). 
cDNA was then added to the RT2 SYBR Green Master Mix 
(SABiosciences, Frederick, MD, USA). All mixtures were applied 
on the Chicken Innate & Adaptive Immune Responses RT2 
Profiler PCR Array (SABiosciences, Frederick, MD, USA). All 
steps were done according to manufacturer’s instructions for the 
ABI 7900HT Fast Real Time PCR System. The data were analyzed 
using Excel-based PCR array Data Analysis Templates. Gene 
expression differences between control and XPC group with a 
P-value < 0.05 and |Fold Change (FC)| > 1.2 were considered as 
significantly influenced by XPC supplementation.
resUlTs
The effect of S. cerevisiae Fermentation 
Product supplementation on cellular 
immunity Parameters: T- and B-cell 
repertoire in immune Organs
As shown in Figure  1, XPC supplementation significantly 
(P < 0.05) increased the T-cell repertoire (CD3+, CD4+, and CD8+ 
T-cells) in the thymus at 28 days of age, 7 days post-NDV vaccine 
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FigUre 1 | lymphocyte subpopulations in thymus at 14, 21, 28, and 42 days of age. Percentage of (a) CD3+; (B) CD4+; (c) CD8+; (D) Bu-1+ lymphocytes in 
control (dark column) and XPC-supplemented (gray column) broilers (1.25 kg/ton; Diamond V Original XPC, Cedar Rapids, IA, USA). n = 5 per treatment per day. 
Data are presented as group means ± SEM. Different letters indicate significant differences (P < 0.05).
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boost. However, at 21 and 42 days of age, only numerically higher 
percentages of CD3+, CD4+, and CD8+ T-cells were observed in 
the thymus of XPC supplemented broilers (Figure 1).
The effect of dietary XPC on lymphocyte subpopulations in 
peripheral blood was not significant (Figure  2). However, the 
proportional change in T-cell marker (CD3 and CD4) staining 
patterns mirrors NDV-specific antibody titers (10) that were 
measured in the same birds. The proportion of positive staining 
T-cells dramatically increased (P < 0.05) at 14 and 28 days of age 
and decreased at 21 and 42 days of age.
In the spleen, dietary XPC did not significantly change T-cell 
subpopulations. As shown in Figure 3, birds supplemented with 
XPC had a significantly (P <  0.05) higher percentage of CD8+ 
T-cells positive staining at 21 days of age. The number of Bu-1+ 
B-cells was significantly (P < 0.05) higher in the spleen of birds 
supplemented with XPC at 14 days of age.
As shown in Figure 4, the supplemented broilers had a signifi-
cantly (P < 0.05) higher percentage of CD4+ and CD8+ T-cells at 
21 days of age in the bursa. The number of Bu-1+ B-cells in the 
bursa was also significantly (P < 0.05) higher at 42 days of age.
gene expression analysis Using 
Quantitative Pcr array
In order to measure the effects of XPC feed additive on the host 
response to a live NDV vaccine strain in  vivo, a qPCR array 
covering 84 immune-associated genes was performed. Tables 2–4 
summarize the significantly modulated (P-value  <  0.05 and 
|FC| > 1.2) genes in the thymus, spleen, and bursa of Fabricius 
of the controls and the XPC-supplemented birds. As shown in 
Figure  5, immune-associated gene expression patterns were 
different between central and peripheral immune organs. At 
14 days of age, the spleen was the major immune organ that was 
significantly modulated by XPC. There were 14 genes significantly 
(P < 0.05) modulated in the spleen. On the other hand, only two 
and three genes were significantly (P < 0.05) modulated in the 
bursa and thymus, respectively (Figure 5).
Interestingly, at 28  days of age (1  week post-boost of the 
vaccination), the pattern of gene expression changed entirely. 
Thymus became the major immune organ that was significantly 
modulated by XPC supplemented. Seventeen genes were signifi-
cantly (P < 0.05) modulated in the thymus. However, only 2 and 
4 genes were significantly (P < 0.05) regulated in the spleen and 
bursa, respectively (Figure 5).
genes Differentially expressed in the 
immune Organs of XPc-supplemented 
Broilers at 14 Days of age
At 14 days of age, 2 weeks after the primary NDV vaccination, 
only three and two genes were significantly (P < 0.05) modulated 
in the thymus and bursa of Fabricius of the XPC group when 
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FigUre 2 | lymphocyte subpopulations in blood at 14, 21, 28, and 42 days of age. Percentage of (a) CD3+; (B) CD4+; (c) CD8+; (D) Bu-1+ lymphocytes in 
control (dark column) and XPC-supplemented (gray column) broilers (1.25 kg/ton; Diamond V Original XPC, Cedar Rapids, IA, USA). n = 5 per treatment per day. 
Data are presented as group means ± SEM. Different letters indicate significant differences (P < 0.05).
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compared with control groups, respectively (Tables  2 and 4). 
The most affected upregulated gene in the thymus at 14 days of 
age was Integrin β2 (ITGB2) (Table  2). Conversely, two genes, 
mitogen-activated protein kinase (MAP kinase) and myeloid 
differentiation primary response gene (MyD88), were downregu-
lated in the thymus at 14 days of age (Table 2).
As shown in Table  3, our results revealed 14 genes in the 
spleen that were significantly (P < 0.05) affected in the treated 
group on 14 days of age, which involved three different functional 
categories: innate immunity, antiviral, and pro-inflammatory. 
The most affected gene affected by XPC supplementation, 
complement component 3 (C3), was sevenfold upregulated 
over the control group. C3 also plays a role in B-cell activa-
tion and is thought to facilitate adaptive immunity (12, 13). 
Several germline-encoded innate immune sensors are among 
the significantly modified genes of the XPC group, including 
toll-like receptors (TLRs), interferon induced with helicase C 
domain 1 (IFIH1), and nucleotide-binding oligomerization 
domain containing 1 (NOD1) (Table 3). IFN-stimulated genes 
and transcription factors, such as interferon (alpha, beta, and 
omega) receptor 1 (IFNAR1), IFN-γ, STAT4, and NFκB, were 
also upregulated in the spleen of XPC-supplemented broilers. 
Two genes involved in apoptosis, Caspase 8 and apoptosis-
related cysteine peptidase (CASP8), and Fas TNF receptor 
superfamily, member 6 (FAS) were also upregulated in the 
spleen of the XPC group at 14  days of age. Gene of cytokine 
IL-17, produced by T-helper (Th) 17 cells, was also significantly 
upregulated in the spleen of XPC-supplemented broilers at 
14 days of age (Table 3).
genes Differentially expressed in immune 
Organs of XPc supplemented Broilers at 
28 Days of age
At day 28 of age (1 week post-boost of the vaccination), 17 (15 
up- and 2 downregulated) and 4 (2 up- and 2 downregulated) 
genes were differentially expressed (P < 0.05) in the thymus and 
bursa of Fabricius, respectively, in XPC-supplemented broilers 
when compared with control (Tables  2 and 4). As shown in 
Table  2, several IFNs, IFN-stimulated genes, and transcription 
factors [such as IFIH1, IFNAR1, Myxovirus resistance 1 (Mx1), 
Interferon regulatory factor (IRF) 1, IRF7, and STAT1] were sig-
nificantly (P < 0.05) upregulated in the thymus of the XPC group 
at 28 days of ages. Several cytokines that contribute to lymphocyte 
proliferation and differentiation (including IL-1R1, IL-2, IL-10, 
and IL-15) were also significantly (P < 0.05) upregulated in the 
thymus of broilers supplemented with dietary XPC at 28 days of 
age (Table 2). Two genes [Chemokine (C–X–C motif) ligand 12 
(stromal cell-derived factor 1) CXCL12 and CD14] were signifi-
cantly (P < 0.05) downregulated in the thymus of the XPC group 
at 28 days of age when compared with the control group. CXCL12 
is a chemokine produced by stromal cells and plays a pivotal role 
in the migration and localization of developing T-cells within 
different zones of the thymus (Table 2).
DiscUssiOn
In the current study, the live-attenuated NDV vaccination model 
on broilers was adopted. The effect of S. cerevisiae fermentation 
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product (Original XPC™, Diamond V) as a natural immu-
nomodulator on central and peripheral immune organs was 
evaluated at the cellular and molecular levels.
The differentially expressed genes (P  <  0.05) at 14 and 
28  days of age were grouped into different functional groups. 
Interestingly, several distinct modes of action were observed. 
Several germline-encoded innate immune sensors were affected 
by XPC supplementation. Pathogens that invade a host are ini-
tially recognized by the innate immune system through germline-
encoded pattern recognition receptor (PRRs). TLRs, NOD-like 
receptors, and RIG-I-like proteins (RLRs) are major classes of 
PRRs with key roles in immune homeostasis and defense against 
infections (14–16). Stimulation of PRRs by pathogen-associated 
molecular patterns plays a crucial role in shaping the profile of 
the subsequent adaptive immune responses. In the current study, 
our results revealed that 2 weeks post primary vaccination with 
the NDV B1 strain, a stronger expression of TLR-2, NOD-1, 
and IFIH-1 was measured in the spleen of XPC-supplemented 
broilers.
Yitbarek et al. (17) reported broilers fed 0.02% yeast-derived 
macromolecule supplements showed TLR2 and TLR4 gene 
upregulation in the spleen at 42  days of age when compared 
with control. Our current findings reveal that when challenged 
with live-attenuated NDV vaccine, broilers fed XPC significantly 
upregulated TLR2, but not TLR4. This inconsistency could result 
from the NDV vaccine challenge. TLR3, NOD-1, and IFIH-1 
are common host sentinel proteins for NDV (18). In this study, 
NOD-1 and IFIH-1 were significantly upregulated in the spleen 
2 weeks post primary vaccination in the XPC group. TLR3 was 
also upregulated despite not reaching statistical significance 
(P = 0.07).
In the chicken, TLR2 is widely distributed in the heart, liver, 
gizzard, muscle, spleen, cecal tonsils, bursa of Fabricius, and liver 
(19). TLR2 has also been detected by RT-PCR in heterophils, 
monocytes, macrophages, B-cells, and T-cells (20, 21). The liga-
tion of TLR2 with various ligands can trigger different immuno-
logical events (22). In mammals, zymosan, a S. cerevisiae cell wall 
derivate, is recognized by TLR2 and induces peripheral tolero-
genic responses via induction of regulatory antigen-presenting 
cells [APCs; (22, 23)]. Thus, the upregulation of TLR2 by XPC 
supplementation in broilers may contribute to maintaining the 
balance of the immune system and preventing innate immunity 
over-reaction in the host.
In the current study, NOD1 and MDA-5 in the spleen were 
able to recognize NDV through CARD-dependent recruitment 
of RIP2, driving activation of MAP kinase and NF-κB. These 
observations are in line with results from previous studies (18). 
At 14  days of age, both type I (IFN-α, P =  0.07 and IFN-β, 
P = 0.07) and type II (IFN-γ) IFN responses were detected by 
qPCR array in the spleen of XPC-supplemented broilers. These 
cytokines may participate in priming natural killer (NK) cells, 
inducing maturation of Th1 cells, and viral clearance (24, 25). 
0
1
2
3
4
5
6
7
8
9
10
day 14 day 21 day 28 day 42
%
C
D
3+
 in
 th
e 
bu
rs
a
Age
Con XPC
0
0.5
1
1.5
2
2.5
3
3.5
4
day 14 day 21 day 28 day 42
Age
Con XPC
b
a
0
0.5
1
1.5
2
2.5
day 14 day 21 day 28 day 42
%
C
D
8+
 in
 th
e 
bu
rs
a
Age
Con XPC
a
b
0
5
10
15
20
25
30
35
day 14 day 21 day 28 day 42
%
B
u-
1+
 in
 th
e 
bu
rs
a
Age
Con XPC
a
b
A B
C D
FigUre 4 | lymphocyte subpopulations in bursa at 14, 21, 28, and 42 days of age. Percentage of (a) CD3+; (B) CD4+; (c) CD8+; (D) Bu-1+ lymphocytes in 
control (dark column) and XPC-supplemented (gray column) broilers (1.25 kg/ton; Diamond V Original XPC, Cedar Rapids, IA, USA). n = 5 per treatment per day. 
Data are presented as group means ± SEM. Different letters indicate significant differences (P < 0.05).
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IFN-γ is also involved in leukocyte attraction, regulation of 
B-cell immunoglobulin production, and class-switching (26). 
These results are consistent with the recent report by Yitbarek 
et al. (17) where the authors showed yeast-derived macromol-
ecules significantly enhanced IFN-γ in spleen compared with 
non-supplemented control birds. However, the up-stream 
signal interferon regulatory factor-1 and 7 were not signifi-
cantly altered in the spleen of XPC-supplemented broilers. The 
downstream effectors of IFN action include Mx1 and MyD88, 
and those genes were not consistently modulated (P >  0.05). 
We also noticed that IL-17, a Th17 cell-produced cytokine, was 
significantly upregulated in the spleen of XPC-supplemented 
broilers. Th17 cells are important in clearing pathogens during 
host defense reactions (27). IL-17 is also a factor that contrib-
utes to the formation of germinal centers of lymphoid follicles 
(28), which is consistent with our flow cytometry data that 
XPC-supplemented broilers have higher percentages of Bu-1+ 
B-cells in the spleen at 14 days of age. These results suggest that 
XPC-supplemented broilers have higher baseline expression 
of IFNs and can keep the innate immune system in stand-by 
mode. As a consequence, supplemented broilers are capable 
of responding to stimuli more rapidly than their non-treated 
counterparts.
In our previous study (10), XPC supplementation was able 
to establish robust NDV-specific humoral immunity against 
an NDV vaccine challenge at 28  days of age, which is 1  week 
earlier than control birds. Since the spleen is the most important 
peripheral lymphoid organ in chickens, we expected to observe 
more conspicuous effects immune-associated genes at this time 
point. Interestingly, our gene expression data revealed that at the 
same time point, more genes were affected in the thymus and 
not in the spleen. It is possible that the timing of that sampling 
point was not optimal. Rue et  al. (29) reported that a virulent 
NDV-CA02 challenge elicited a strong innate immune response 
within 72 h in the spleen of specific pathogen-free chicken (29). 
Despite broilers in the current study receiving a live-attenuated 
NDV LaSota strain booster, after 7 days the acute effects of the 
viral challenge may be over. The gene expression profile in the 
thymus of XPC-supplemented broilers at 28 days of age, in spite 
of the fact that no significant IFN regulation was observed, 
showed enhanced expression of the type I IFN receptor. The 
activation of type I IFN receptor results in the induction of IRF 
1 and 7 (P = 0.056) required for regulation of the downstream 
interferon stimulatory gene. In this study, the expression of Mx1 
gene, important for resistance against viral infection, and STAT1 
were significantly induced. IFNs are a family of cytokines that 
play a central role in innate immunity to viruses. In the thymus, 
IFNs are constitutively expressed in the medulla and have a direct 
impact on the development of T-cells in the thymus (16). The 
significantly upregulated IFN-associated genes may contribute 
TaBle 4 | genes significantly up- or downregulated in the bursa with 
supplementation of XPc.a,b
Bursa Day 14 Day 28
gene Fold regulation (treated 
vs. control)
P-value Fold regulation 
(treated vs. control)
P-value
CASP1 −1.2477 0.0397 – –
CD28 – – −1.202 0.0341
CRP – – 2.05 0.0293
CSF2 1.5786 0.0429 – –
JAK2 – – 1.4361 0.0103
TLR21 – – −2.7123 0.0186
aDiamond V Original XPC, Cedar Rapids, IA, USA. Supplemented in the diet at 0 
(control) or 1.25 kg/ton of feed.
bFold regulation is the fold change (upregulation as a positive value or downregulation 
as a negative value) of genes in birds supplemented with XPC compared to control. A 
blank value indicates no differences between the two groups of birds.
TaBle 3 | genes significantly upregulated in the spleen with 
supplementation of XPc.a,b
spleen Day 14 Day 28
gene Fold regulation 
(treated vs. 
control)
P-value Fold regulation 
(treated vs. 
control)
P-value
C3 7.3613 0.0179 – –
CASP8 1.3845 0.0328 – –
CRP – – 2.7613 0.0086
FAS 3.119 0.0231 – –
FASLG – – 1.5077 0.0203
IFIH1 2.2836 0.0489 – –
IFNAR1 1.5519 0.0257 – –
IFNG 3.0904 0.0270 – –
IL17C 1.6033 0.0473 – –
LY96 2.3354 0.0280 – –
Mitogen-activated 
protein kinase 8
2.4213 0.0185 – –
MBL2 5.1335 0.0224 – –
NFKB1 1.4967 0.0147 – –
NOD1 1.3814 0.0014 – –
Signal transducer 
and activator of 
transcription 4
2.3667 0.0026 – –
TLR2-2 1.9828 0.0028 – –
aDiamond V Original XPC, Cedar Rapids, IA, USA. Supplemented in the diet at 0 
(Control) or 1.25 kg/ton of feed.
bFold regulation is the fold change (upregulation as a positive value or downregulation 
as a negative value) of genes in birds supplemented with XPC compared to control.  
A blank value indicates no differences between the two groups of birds.
TaBle 2 | genes significantly up- or downregulated in the thymus with 
supplementation of XPc.a,b
Thymus Day 14 Day 28
gene Fold 
regulation 
(XPc vs. 
control)
P-value Fold 
regulation 
(XPc vs. 
control)
P-value
CD14 – – −1.5199 0.0274
CD80 – – 1.2924 0.0013
CD86 – – 1.631 0.0466
CXCL12 – – −1.5959 0.0311
FAS – – 1.95 0.0033
IFIH1 – – 1.4894 0.0251
IFNAR1 – – 1.3719 0.0431
IL10 – – 1.436 0.0349
IL15 – – 1.5614 0.0002
IL1R1 – – 1.8698 0.0205
IL2 – – 1.7623 0.0146
IL8L1 – – 2.2771 0.0051
IRF1 – – 1.4805 0.0199
ITGB2 1.5158 0.0098 – –
Mitogen-activated protein 
kinase 8
−1.397 0.0268 – –
MX1 – – 2.9625 0.0453
Myeloid differentiation 
primary response gene 88
−2.376 0.0076 – –
PTGS2 – – 1.6087 0.0455
STAT1 – – 1.6156 0.0038
TLR3 – – 1.6099 0.0051
aDiamond V Original XPC, Cedar Rapids, IA, USA. Supplemented in the diet at 0 
(control) or 1.25 kg/ton of feed.
bFold regulation is the fold change (upregulation as a positive value or downregulation 
as a negative value) of genes in birds supplemented with XPC compared to control. A 
blank value indicates no differences between the two groups of birds.
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to innate immune responses and also may shape the repertoire 
of T-cells in the thymus, which is consistent with our flow cyto-
metric data.
In the present study, several cytokines were significantly 
upregulated in the thymus of XPC-supplemented broilers at 
28 day of age. In mammals, IL-1R expression in the thymus is 
restricted on immature T-cells. However, the function of IL-1R 
in avian species is still unknown (30). IL-2 is important for the 
production, function, and homeostasis of CD4+CD25+ Treg cells. 
It is also a potent T-cell growth factor during the initiation of 
immune responses (31, 32). IL-10 is a pleiotropic cytokine. 
The expression of IL-10 plays a critical role in limiting immune 
response to pathogens, including downregulation of Th1 
cytokines, MHC-molecules, and co-stimulatory molecules on 
macrophages (33). Taken together, the significant upregulation of 
IL-2 and IL-10 in the thymus of supplemented broilers at 28 days 
of age indicates XPC promotes the developmental production of 
suppressive Treg cells and suppresses the innate immune response, 
thus contributing to the proportional, i.e., transient nature, of the 
innate immune responses induced by NDV vaccine challenge. 
IL-15, a cytokine essential for NK cell development, functional 
maturation and activation was significantly upregulated in sup-
plemented broilers. This result is in concert with previous studies 
showing XPC treatment induced activation markers CD69 and 
CD25 on CD3+–CD56+ NK cells in mammals (34). CXCL12 is 
produced by thymus stromal cells in the cortex and play a pivotal 
role guiding the traffic of T-cell precursors during early devel-
opment (35, 36). The downregulation of CXCL12 in the XPC 
group indicates XPC supplement accelerated the development 
of T-cells compared with the control group. This result is also 
consistent with our flow cytometric data showing significantly 
more CD4+ and CD8+ T-cells in the thymus of the XPC group at 
28 days of age.
CMI is a crucial factor for development of protection and 
viral clearance as well as vaccine-induced protective immunity 
in mammals and chickens (37). The subpopulations of T-cells, 
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including cytokine-secreting CD4+ T-helper cells and CD8+ 
cytotoxic T-cells (CTL), constitute the main components of the 
CMI responses.
Our data indicate that dietary XPC increased the repertoire of 
both effector T-cells [T-helper (CD4+) and Cytotoxic (CD8+)] in 
the thymus 1 week after NDV vaccine challenge. The thymus has 
been shown to be a sensitive immune organ following exposure 
to immune toxins and endogenous corticosteroids, especially 
the cortex T-cells. An increase in lymphocyte numbers in the 
thymus is usually a response to antigenic stimulation, and the 
cell population is mixed in contrast to the more homogene-
ous neoplastic population. The thymus is a primary lymphoid 
organ, able to generate mature T-cells that eventually colonize 
T-cell-dependent areas in secondary lymphoid organs, and 
is essential for peripheral T-cell renewal. Higher percentages 
of effector T-cells in the thymus signify a more diverse T-cell 
repertoire to aid in the host’s fight against pathogens. Therefore, 
XPC-supplemented broilers are more capable of establishing 
protective immunity thanks to antigen-specific T-cell expan-
sion, further facilitating subsequent proliferation and differen-
tiation of CD4+ Th cells and CD8+ CTL. In the current study, 
the output of naïve T-cells may have contributed to the NDV 
vaccine-induced humoral immune response. These results are 
consistent with our previous report that NDV-specific antibody 
titers peak 1 week post-boost [28 days of age; (10)]. We expect 
matured naïve T-cells in the thymus to migrate to the periphery 
and to contribute to the shaping of the lymphocyte distribution 
in circulation and spleen. However, no differences between sup-
plemented broiler and non-supplemented control were observed 
in the percentage of effector T-cells and B-cells in the circulation 
across all the experiment sampling time points. As previously 
mentioned, sampling 7  days post-boost may be too late for 
measuring the dynamic change of lymphocyte subpopulations 
in the circulation and the spleen.
Also, our data show that inclusion of XPC into the feed signifi-
cantly (P < 0.05) increased the percentage of Bu-1+ B-cells in the 
spleen at 14 days of age. Bu-1 marker is expressed on early and 
mature B cells, except plasma cells (38). Plasma cells are effector 
B-cells that can secrete antibodies. Our current study suggests 
that the higher percentage of Bu-1+ B-cells in the spleen indicates 
XPC promotes the growth and maturation of B-cells in the spleen. 
These results are consistent with our previous finding that sup-
plemented broilers have more white pulp in the spleen at 14 days 
of age (10).
Furthermore, supplementation with XPC significantly 
increased the percentage of CD4+ and CD8+ in the bursa at 21 days 
of age. Also, significantly higher percentages of Bu-1+ B-cells were 
measured in the supplemented group at 42 days of age. The bursa 
of Fabricius is a unique primary lymphoid organ where B-cell 
lymphopoiesis takes place (39). Higher B-cell proliferation rates 
were seen in the supplemented group, indicating a more diverse 
B-cell repertoire. This might also contribute to enhancement of 
the humoral immune response.
Only very limited resident T-cells reside in the uninfected 
bursa. How the inclusion of XPC affects the T-cell popula-
tion in the bursa at 21 days of age and how it contributes to 
the immune response against NDV vaccine requires further 
investigation.
Our current study suggests inclusion of XPC in the feed 
modulates more than one aspect of the coordinated immune 
response to NDV vaccine challenge through activation of genes 
involved in the innate immune response and moderation of 
potentially excessive immune responses. More importantly, XPC 
triggers the innate immune system mildly, thereby priming the 
defense mechanisms, thus shortening the time for establishing 
the adaptive immune response.
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